A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use

Price D, Asukai Y, Ananthapavan J, Malcolm B, Radwan A, Keyzor I

Appl Health Econ Health Policy 2013; 11(3): 259-74. [PubMed] [Full Text]